
Opinion|Videos|July 30, 2024
Transition of Care for Neurofibromatosis Type 1 Related Plexiform Neurofibroma from Adolescent to Adulthood
Author(s)Kaleb H. Yohay, MD
An expert in NF1-PN describes their approach to treatment decision-making for adolescents versus adults, and identifies key barriers and unmet needs in the transition from adolescent to adult care for patients with this condition.
Advertisement
Episodes in this series

- An expert in NF1-PN describes their approach to treatment decision-making for adolescents versus adults, and identifies key barriers and unmet needs in the transition from adolescent to adult care for patients with this condition.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
POLARIS-AD Phase 3 Trial of PDE5 Inhibitor AR1001 Completes Treatment Phase With Favorable Safety Profile
2
Focused Ultrasound vs DBS for Parkinson Disease: What New Bilateral Data Tell Us
3
FDA Approves At-Home Starting Dose for Lecanemab, Marking First Subcutaneous Initiation Option for Alzheimer Disease Treatment
4
Novel Anti-Tau Seeding Antibody MK-2214 Achieves Near-Complete CSF Target Engagement in Phase 1
5


















